(CTPNV) CTP - Ratings and Ratios
Industrial Properties, Office Campuses, Solar Energy, Retail, Hotel
CTPNV EPS (Earnings per Share)
CTPNV Revenue
Description: CTPNV CTP
CTP N.V. is a commercial real estate development company operating in Western Europe and Central and Eastern Europe, offering a diverse portfolio of industrial, office, retail, and hotel properties, as well as solar energy projects. The companys industrial properties cater to various applications, including warehousing, manufacturing, and research and development.
As a significant player in the European real estate market, CTP N.V.s performance can be evaluated using key performance indicators (KPIs) such as Funds From Operations (FFO) per share, Net Operating Income (NOI) margin, and debt-to-equity ratio. A strong FFO per share growth indicates the companys ability to generate cash from its operations, while a high NOI margin suggests efficient property management. A reasonable debt-to-equity ratio is crucial in maintaining a stable financial position.
With a market capitalization of €8.6 billion, CTP N.V. is a substantial entity in the European real estate development sector. Its price-to-earnings ratio of 8.02 and forward P/E of 20.79 suggest that the companys current earnings are undervalued, but future growth expectations are high. The return on equity (RoE) of 14.65% indicates a relatively strong profitability compared to its peers.
To further analyze CTP N.V.s performance, it is essential to examine its occupancy rates, rental income growth, and property portfolio diversification. A high occupancy rate and steady rental income growth can indicate a stable and growing revenue stream. A diversified portfolio across different asset classes and geographies can help mitigate risks and capitalize on emerging opportunities.
CTPNV Stock Overview
| Market Cap in USD | 10,367m |
| Sub-Industry | Real Estate Development |
| IPO / Inception |
CTPNV Stock Ratings
| Growth Rating | 74.6% |
| Fundamental | 69.5% |
| Dividend Rating | 63.3% |
| Return 12m vs S&P 500 | -6.76% |
| Analyst Rating | - |
CTPNV Dividends
| Dividend Yield 12m | 1.75% |
| Yield on Cost 5y | 2.44% |
| Annual Growth 5y | 35.02% |
| Payout Consistency | 100.0% |
| Payout Ratio | 13.4% |
CTPNV Growth Ratios
| Growth Correlation 3m | 59.9% |
| Growth Correlation 12m | 76.6% |
| Growth Correlation 5y | 38.6% |
| CAGR 5y | 26.19% |
| CAGR/Max DD 3y | 1.24 |
| CAGR/Mean DD 3y | 6.18 |
| Sharpe Ratio 12m | 1.08 |
| Alpha | -8.33 |
| Beta | 0.989 |
| Volatility | 22.24% |
| Current Volume | 73.1k |
| Average Volume 20d | 76.2k |
| Stop Loss | 17.6 (-3.2%) |
| Signal | -0.48 |
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (1.17b TTM) > 0 and > 6% of Revenue (6% = 55.3m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA -0.57pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.98% (prev 85.55%; Δ -73.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.02 (>3.0%) and CFO 314.5m <= Net Income 1.17b (YES >=105%, WARN >=100%) |
| Net Debt (7.69b) to EBITDA (1.45b) ratio: 5.31 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (479.3m) change vs 12m ago 5.75% (target <= -2.0% for YES) |
| Gross Margin 79.08% (prev 81.19%; Δ -2.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 5.27% (prev 4.56%; Δ 0.71pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.26 (EBITDA TTM 1.45b / Interest Expense TTM 275.4m) >= 6 (WARN >= 3) |
Altman Z'' 1.90
| (A) 0.01 = (Total Current Assets 1.15b - Total Current Liabilities 1.04b) / Total Assets 18.57b |
| (B) 0.25 = Retained Earnings (Balance) 4.73b / Total Assets 18.57b |
| (C) 0.08 = EBIT TTM 1.45b / Avg Total Assets 17.51b |
| (D) 0.45 = Book Value of Equity 4.73b / Total Liabilities 10.58b |
| Total Rating: 1.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.49
| 1. Piotroski 2.50pt = -2.50 |
| 2. FCF Yield 1.73% = 0.87 |
| 3. FCF Margin 31.11% = 7.50 |
| 4. Debt/Equity 1.07 = 1.96 |
| 5. Debt/Ebitda 5.89 = -2.50 |
| 6. ROIC - WACC 2.10% = 2.62 |
| 7. RoE 15.65% = 1.30 |
| 8. Rev. Trend 93.90% = 4.70 |
| 9. Rev. CAGR 17.16% = 2.15 |
| 10. EPS Trend 35.98% = 0.90 |
| 11. EPS CAGR 62.48% = 2.50 |
What is the price of CTPNV shares?
Over the past week, the price has changed by -0.44%, over one month by -3.81%, over three months by +8.21% and over the past year by +11.01%.
Is CTP a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CTPNV is around 18.69 EUR . This means that CTPNV is currently overvalued and has a potential downside of 2.81%.
Is CTPNV a buy, sell or hold?
What are the forecasts/targets for the CTPNV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.8 | 14.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 20.2 | 11.3% |
CTPNV Fundamental Data Overview
Market Cap EUR = 8.86b (8.86b EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 848.4m EUR (Cash only, last quarter)
P/E Trailing = 7.176
P/E Forward = 18.3824
P/S = 9.6239
P/B = 1.0691
P/EG = 2.7596
Beta = 0.904
Revenue TTM = 922.1m EUR
EBIT TTM = 1.45b EUR
EBITDA TTM = 1.45b EUR
Long Term Debt = 7.84b EUR (from longTermDebt, last quarter)
Short Term Debt = 693.2m EUR (from shortLongTermDebt, last quarter)
Debt = 8.54b EUR (Calculated: Short Term 693.2m + Long Term 7.84b)
Net Debt = 7.69b EUR (from netDebt column, last quarter)
Enterprise Value = 16.55b EUR (8.86b + Debt 8.54b - CCE 848.4m)
Interest Coverage Ratio = 5.26 (Ebit TTM 1.45b / Interest Expense TTM 275.4m)
FCF Yield = 1.73% (FCF TTM 286.9m / Enterprise Value 16.55b)
FCF Margin = 31.11% (FCF TTM 286.9m / Revenue TTM 922.1m)
Net Margin = 127.3% (Net Income TTM 1.17b / Revenue TTM 922.1m)
Gross Margin = 79.08% ((Revenue TTM 922.1m - Cost of Revenue TTM 192.9m) / Revenue TTM)
Tobins Q-Ratio = 3.50 (Enterprise Value 16.55b / Book Value Of Equity 4.73b)
Interest Expense / Debt = 0.86% (Interest Expense 73.2m / Debt 8.54b)
Taxrate = 18.70% (248.7m / 1.33b)
NOPAT = 1.18b (EBIT 1.45b * (1 - 18.70%))
Current Ratio = 1.11 (Total Current Assets 1.15b / Total Current Liabilities 1.04b)
Debt / Equity = 1.07 (Debt 8.54b / last Quarter total Stockholder Equity 7.99b)
Debt / EBITDA = 5.89 (Net Debt 7.69b / EBITDA 1.45b)
Debt / FCF = 29.75 (Debt 8.54b / FCF TTM 286.9m)
Total Stockholder Equity = 7.50b (last 4 quarters mean)
RoA = 6.32% (Net Income 1.17b, Total Assets 18.57b )
RoE = 15.65% (Net Income TTM 1.17b / Total Stockholder Equity 7.50b)
RoCE = 9.45% (Ebit 1.45b / (Equity 7.50b + L.T.Debt 7.84b))
RoIC = 7.36% (NOPAT 1.18b / Invested Capital 16.00b)
WACC = 5.26% (E(8.86b)/V(17.39b) * Re(9.66%)) + (D(8.54b)/V(17.39b) * Rd(0.86%) * (1-Tc(0.19)))
Shares Correlation 3-Years: 92.99 | Cagr: 2.60%
Discount Rate = 9.66% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.63% ; FCFE base≈311.5m ; Y1≈352.6m ; Y5≈479.1m
Fair Price DCF = 13.06 (DCF Value 6.26b / Shares Outstanding 479.3m; 5y FCF grow 15.33% → 3.0% )
Revenue Correlation: 93.90 | Revenue CAGR: 17.16%
Rev Growth-of-Growth: 1.62
EPS Correlation: 35.98 | EPS CAGR: 62.48%
EPS Growth-of-Growth: -21.18